Mst 1 and Mst 2 maintain hepatocyte quiescence and suppress the development of hepatocellular carcinoma through inactivation of the Yap 1 oncogene

Hippo-Lats-Yorkie signaling regulates tissue overgrowth and tumorigenesis in Drosophila. We show that the Mst1 and Mst2 protein kinases, the mammalian Hippo orthologs, are cleaved and constitutively activated in the mouse liver. Combined Mst1/2 deficiency in the liver results in loss of inhibitory Ser127 phosphorylation of the Yorkie ortholog, Yap1, massive overgrowth, and hepatocellular carcinoma (HCC). Reexpression of Mst1 in HCC-derived cell lines promotes Yap1 Ser127 phosphorylation and inactivation, and abrogates their tumorigenicity. Notably, Mst1/2 inactivates Yap1 in liver through an intermediary kinase distinct from Lats1/2. Approximately 30% of human HCCs show low Yap1(Ser127) phosphorylation and a majority exhibit loss of cleaved, activated Mst1. Mst1/2 inhibition of Yap1 is an important pathway for tumor suppression in liver relevant to human HCC. Significance—The pathways that regulate quiescence and tumor suppression in the liver have not been fully elucidated. We show that the Mst1 and Mst2 kinases are tumor suppressors and regulators of liver size in adults and that negative regulation of the transcriptional coactivator, Yap1, is central to Mst1/2 tumor suppressor function. Loss of both Mst1 and Mst2 is sufficient to initiate hepatocyte proliferation, resulting in dramatic liver overgrowth, resistance to pro-apoptotic *Address correspondence to: Nabeel Bardeesy Ph.D., Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, CPZN4216, 185 Cambridge Street, Boston, Massachusetts 02114, Tel:617-643-2579, Fax:617-643-3170, nelbardeesy@partners.org or Joseph Avruch M.D., Diabetes Research Lab, Department of Molecular Biology, Massachusetts General Hospital, Simches Research Bldg, 6408, 185 Cambridge St., Boston, MA 02114, Tel:617-726-6909, Fax:617-726-5649, avruch@molbio.mgh.harvard.edu. ^These authors contributed equally Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. NIH Public Access

[1]  K. Katagiri,et al.  Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes , 2009, The EMBO journal.

[2]  R. Xavier,et al.  Rassf Family of Tumor Suppressor Polypeptides* , 2009, Journal of Biological Chemistry.

[3]  Junying Yuan,et al.  The Jekyll and Hyde functions of caspases. , 2009, Developmental cell.

[4]  R. Schulte‐Hermann,et al.  NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A. , 2009, Cancer research.

[5]  R. Xavier,et al.  The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells , 2008, Proceedings of the National Academy of Sciences.

[6]  Brian A. Hemmings,et al.  NDR Kinase Is Activated by RASSF1A/MST1 in Response to Fas Receptor Stimulation and Promotes Apoptosis , 2008, Current Biology.

[7]  K. Guan,et al.  The Hippo-YAP pathway: new connections between regulation of organ size and cancer. , 2008, Current opinion in cell biology.

[8]  H. Fearnhead,et al.  A non-apoptotic role for caspase-9 in muscle differentiation , 2008, Journal of Cell Science.

[9]  K. Irvine,et al.  The Fat and Warts signaling pathways: new insights into their regulation, mechanism and conservation , 2008, Development.

[10]  Jiandie D. Lin,et al.  TEAD mediates YAP-dependent gene induction and growth control. , 2008, Genes & development.

[11]  J. Llovet,et al.  Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps , 2008, Current opinion in oncology.

[12]  Ronen Marmorstein,et al.  Biochemical analysis of MST1 kinase: elucidation of a C-terminal regulatory region. , 2008, Biochemistry.

[13]  Y. Kong,et al.  A crucial role of WW45 in developing epithelial tissues in the mouse , 2008, The EMBO journal.

[14]  Q. Zeng,et al.  A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. , 2008, Cancer research.

[15]  J. Avruch,et al.  MOBKL1A/MOBKL1B Phosphorylation by MST1 and MST2 Inhibits Cell Proliferation , 2008, Current Biology.

[16]  Kevin J. Cheung,et al.  Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP* , 2008, Journal of Biological Chemistry.

[17]  Zhengyu Zha,et al.  TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway , 2008, Molecular and Cellular Biology.

[18]  R. Jaenisch,et al.  YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells , 2007, Current Biology.

[19]  Li Li,et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.

[20]  P. Yelick,et al.  The pro‐apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1 , 2007, The EMBO journal.

[21]  G. Feldmann,et al.  Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.

[22]  H. Donninger,et al.  The RASSF1A tumor suppressor , 2007, Journal of Cell Science.

[23]  Jianmin Zhang,et al.  Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon , 2006, Proceedings of the National Academy of Sciences.

[24]  K. Katagiri,et al.  Spatiotemporal regulation of the kinase Mst1 by binding protein RAPL is critical for lymphocyte polarity and adhesion , 2006, Nature Immunology.

[25]  M. Wigler,et al.  Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic Approach , 2006, Cell.

[26]  S. Thorgeirsson,et al.  Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. , 2006, Gastroenterology.

[27]  M. Giovannini,et al.  Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin. , 2005, Genes & development.

[28]  Jianbin Huang,et al.  The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP , 2005, Cell.

[29]  E. Nigg,et al.  The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1 , 2005, Oncogene.

[30]  B. Bruneau,et al.  Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity , 2004, The EMBO journal.

[31]  J. Avruch,et al.  Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. , 2004, The Biochemical journal.

[32]  A. Burroughs,et al.  Hepatocellular carcinoma , 2003, The Lancet.

[33]  Ryan S. Udan,et al.  Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway , 2003, Nature Cell Biology.

[34]  Shian Wu,et al.  hippo Encodes a Ste-20 Family Protein Kinase that Restricts Cell Proliferation and Promotes Apoptosis in Conjunction with salvador and warts , 2003, Cell.

[35]  I. Hariharan,et al.  The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis , 2003, Cell.

[36]  Jonathan Chernoff,et al.  Apoptotic Phosphorylation of Histone H2B Is Mediated by Mammalian Sterile Twenty Kinase , 2003, Cell.

[37]  D. Haber,et al.  salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines , 2002, Cell.

[38]  R. Slack,et al.  Caspase 3 activity is required for skeletal muscle differentiation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Wissenschaftliche Berichte,et al.  The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44 , 2002 .

[40]  N. Masuyama,et al.  Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Ohyama,et al.  MST, a Physiological Caspase Substrate, Highly Sensitizes Apoptosis Both Upstream and Downstream of Caspase Activation* , 2001, The Journal of Biological Chemistry.

[42]  Norinobu M. Watanabe,et al.  The Ste20 group kinases as regulators of MAP kinase cascades. , 2001, Trends in cell biology.

[43]  E. Krebs,et al.  Caspase‐mediated activation and induction of apoptosis by the mammalian Ste20‐like kinase Mst1 , 1998, The EMBO journal.